1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-

1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- Struktur
344418-92-4
CAS-Nr.
344418-92-4
Englisch Name:
1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-
Synonyma:
Tofacitinib Impurity 28;rac-Tofacitinib;rac-Tofacitinib (Mixture of Diastereomers);Tofacitinib Impurity 34 (Mixture of Diastereomers);Rac-Tofacitinib Citrate (Mixture Of Diastereomers);4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-;1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-;3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
CBNumber:
CB72667808
Summenformel:
C16H20N6O
Molgewicht:
312.37
MOL-Datei:
344418-92-4.mol

1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- Eigenschaften

Sicherheit

1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile is used as a reagent in the study of pharmaceutical combination therapies for the treatment or prevention of arthritis.

1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo- Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 28)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Standardpharm Co. Ltd.
86-714-3992388
overseasales1@yongstandards.com United States 14336 58
Career Henan Chemica Co
+86-0371-86658258 +8613203830695
laboratory@coreychem.com China 30250 58
ANHUI WITOP BIOTECH CO., LTD
+8615255079626
eric@witopchemical.com China 23556 58
China National Standard Pharmaceutical Corporation Limited
+8615391658522
overseasales@yongstandards.com China 11927 58
Shanghai Kewel Chemical Co., Ltd. 021-64609169 18901607656
greensnown@163.com China 9911 50
Nanjing XiZe Biotechnology CO., Ltd. 025-66023220 0086-15250997978
1511893459@qq.com China 7787 55
Hubei Yangxin Medical Technology Co., Ltd. 15374522761
3003392093@qq.com China 8345 55
Shenzhen SUNGENING Bio-Medical Co., Ltd. 0755-28967200 13631290199
wxf@sungening.com China 9592 60
Zhuhai Yourun Co., Ltd. 0756-6811852 13923369215
zhuhaiyourun@126.com China 229 55
XinYao(Shenzhen) Biological Technology Co., Ltd. 0755-89880280
3004662104@qq.com China 1830 58

344418-92-4()Verwandte Suche:


  • rac-Tofacitinib
  • 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-
  • 3-[4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
  • rac-Tofacitinib (Mixture of Diastereomers)
  • 4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile
  • Rac-Tofacitinib Citrate (Mixture Of Diastereomers)
  • Tofacitinib Impurity 28
  • 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-β-oxo-
  • Tofacitinib Impurity 34 (Mixture of Diastereomers)
  • 344418-92-4
Copyright 2019 © ChemicalBook. All rights reserved